Compound profile Semaglutide: compound profile, literature landscape and handling notes Semaglutide in one paragraph Semaglutide is a synthetic analog of human glucagon-like peptide-1 engineered for protease resistance and albumin binding, and it is the most extensively documented single-receptor incretin agonist in the published literature
Shi Q, Cheng Y, Dong X, Zhang M, Pei C, Zhang M
Increase to 0.5mg : After 4 weeks, the dose is typically increased to 0.5mg
Never Freeze: Freezing can irreversibly damage the peptide molecules, rendering the medication useless and potentially harmful
You'll complete a quick health questionnaire (free, no commitment), and one of our health advisors will reach out to discuss your goals and determine if you're a candidate